Article Information
vol. 4 no. 146 146ra107
- Received for publication April 30, 2012
- Accepted for publication July 6, 2012
- .
Author Information
- Katharine N. Bossart1,2,*,
- Barry Rockx3,4,*,
- Friederike Feldmann5,
- Doug Brining6,
- Dana Scott6,
- Rachel LaCasse6,
- Joan B. Geisbert7,8,
- Yan-Ru Feng9,
- Yee-Peng Chan9,
- Andrew C. Hickey1,2,
- Christopher C. Broder9,†,
- Heinz Feldmann3,10 and
- Thomas W. Geisbert7,8
- 1Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.
- 2National Emerging Infectious Diseases Laboratories Institute, Boston University School of Medicine, Boston, MA 02118, USA.
- 3Laboratory of Virology, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT 59840, USA.
- 4Sealy Center for Vaccine Development, Departments of Pathology and Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555–0610, USA.
- 5Offices of Operations and Management, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT 59840, USA.
- 6Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT 59840, USA.
- 7Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA.
- 8Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550, USA.
- 9Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD 20814, USA.
- 10Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, MB R3T 2N2, Canada.
- ↵†To whom correspondence should be addressed. E-mail: christopher.broder{at}usuhs.edu